2m 2m 2m 2m 2m 2m 2m
ATEA PHARMA (AVIR)
NASDAQ
$5.33+$0.02 (+0.28%)
Price as of Sep 11, 2026 6:44 PM EDT- $425.9MMarket Cap
- 69.11%1-Year Change
- BiotechnologyIndustry
ATEA PHARMA (AVIR)
$5.33+$0.02 (+0.28%)
AVIR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.31 | ||
Change | +$0.13 (+2.51%) | ||
Open | $5.23 | ||
High | $5.41 | ||
Low | $5.18 | ||
Previous Close | $5.18 | ||
Volume | 489,562 | ||
30-Day Average Volume | 256,112 | ||
1-Week Change | -8.92% | ||
1-Month Change | 5.15% | ||
1-Year Change | 69.11% | ||
3-Year Change | 60.42% | ||
5-Year Change | -81.43% | ||
Fundamentals | |||
Shares Outstanding | 80.2M | ||
Total Assets | $232.3M | ||
Market Cap | $425.9M | ||
Enterprise Value | $349.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.9M | ||
Free Cash Flow | -$37.1M | ||
EBIT | -$32.9M | ||
EBITDA | -$32.8M | ||
Net Working Capital | $200.5M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -13 | ||
PEG | -0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 11 | ||
Last Split Date | 02/14/2018 | ||
Earnings & Revenue